These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29704271)

  • 1. Commentary on 'Gender differences in clinical registration trials; is there a real problem?' by Labots et al.
    Gispen-de Wied C; de Boer A
    Br J Clin Pharmacol; 2018 Aug; 84(8):1639-1640. PubMed ID: 29704271
    [No Abstract]   [Full Text] [Related]  

  • 2. Gender Eligibility Descriptions for Clinical Trials.
    Lee TH; Streed CG
    JAMA; 2024 Apr; 331(16):1415-1416. PubMed ID: 38526485
    [No Abstract]   [Full Text] [Related]  

  • 3. Gender Eligibility Descriptions for Clinical Trials-Reply.
    Mohan S; Tse T
    JAMA; 2024 Apr; 331(16):1416-1417. PubMed ID: 38526481
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterizing Gender Eligibility Descriptions for Clinical Trials Registered on ClinicalTrials.gov.
    Burton A; Mohan S; Puplampu-Dove Y; Tse T
    JAMA; 2023 Nov; 330(20):2019-2021. PubMed ID: 37948067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Race, gender, drug use, and participation in AIDS clinical trials. Lessons from a municipal hospital cohort.
    Stone VE; Mauch MY; Steger K; Janas SF; Craven DE
    J Gen Intern Med; 1997 Mar; 12(3):150-7. PubMed ID: 9100139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Third party reimbursement for participation in cancer clinical trials: a proposal for legislation.
    Plaue GM
    J Contemp Health Law Policy; 2000; 16(2):305-54. PubMed ID: 10921232
    [No Abstract]   [Full Text] [Related]  

  • 7. Eligibility of real-life patients with COPD for inclusion in RCTs: a commentary.
    Battaglia S; Scichilone N
    Respir Res; 2017 Jan; 18(1):5. PubMed ID: 28057007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reevaluating Eligibility Criteria - Balancing Patient Protection and Participation in Oncology Trials.
    Beaver JA; Ison G; Pazdur R
    N Engl J Med; 2017 Apr; 376(16):1504-1505. PubMed ID: 28423289
    [No Abstract]   [Full Text] [Related]  

  • 9. Eligibility determination for clinical trials: development of a case review process at a chiropractic research center.
    Vining RD; Salsbury SA; Pohlman KA
    Trials; 2014 Oct; 15():406. PubMed ID: 25344427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial participation after myocardial infarction in a national cardiovascular data registry.
    Udell JA; Wang TY; Li S; Kohli P; Roe MT; de Lemos JA; Wiviott SD
    JAMA; 2014 Aug; 312(8):841-3. PubMed ID: 25157729
    [No Abstract]   [Full Text] [Related]  

  • 11. Semantic query generation from eligibility criteria in clinical trials.
    Patel CO; Cimino JJ
    AMIA Annu Symp Proc; 2007 Oct; ():1070. PubMed ID: 18694168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing the Participation of Pregnant Women in Clinical Trials.
    Heyrana K; Byers HM; Stratton P
    JAMA; 2018 Nov; 320(20):2077-2078. PubMed ID: 30422300
    [No Abstract]   [Full Text] [Related]  

  • 13. Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum.
    Patel YA; Imperial JC; Muir AJ; Anstee QM; DeBrota D; Dimick-Santos L; Filozof C; Mehta R; Sanyal AJ; Schabel E; Neuschwander-Tetri BA; Miller V;
    Gastroenterology; 2017 Sep; 153(3):621-625.e7. PubMed ID: 28757264
    [No Abstract]   [Full Text] [Related]  

  • 14. Rethinking Eligibility for Experimental Clinical Trials.
    Gibbs L
    JAMA Neurol; 2018 Jan; 75(1):22-23. PubMed ID: 29181505
    [No Abstract]   [Full Text] [Related]  

  • 15. A methodology for determining patients' eligibility for clinical trials.
    Tu SW; Kemper CA; Lane NM; Carlson RW; Musen MA
    Methods Inf Med; 1993 Aug; 32(4):317-25. PubMed ID: 8412828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria.
    Bonomi P; Blumenthal G; Ferris AS; Stewart DJ; Selig WKD; Krug LM; Allen J; Ison G; Langer CJ; Melemed A; Odogwu L; Basu Roy U; Sandler A
    J Thorac Oncol; 2018 Jun; 13(6):748-751. PubMed ID: 29793646
    [No Abstract]   [Full Text] [Related]  

  • 17. Choosing between randomised and non-randomised studies: a systematic review.
    Britton A; McKee M; Black N; McPherson K; Sanderson C; Bain C
    Health Technol Assess; 1998; 2(13):i-iv, 1-124. PubMed ID: 9793791
    [No Abstract]   [Full Text] [Related]  

  • 18. Rethinking trial eligibility in the NCD era.
    Lancet Oncol; 2015 Mar; 16(3):233. PubMed ID: 25752544
    [No Abstract]   [Full Text] [Related]  

  • 19. Generating medical logic modules for clinical trial eligibility criteria.
    Parker CG; Embley DW
    AMIA Annu Symp Proc; 2003; 2003():964. PubMed ID: 14728468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age as a criterion for eligibility in a lung cancer clinical trial.
    Lee JY; Marks JE; Siompson JR
    Am J Clin Oncol; 1982 Aug; 5(4):449-52. PubMed ID: 6287837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.